Stivarga® (regorafenib)
for Gastrointestinal stromal tumor
Stivarga (regorafenib) is a targeted therapy used to treat colorectal cancer, liver cancer, and gastrointestinal stromal tumors (GIST). It works by interfering with cancer cell growth and spread, helping to slow or stop tumor progression. Stivarga is an oral kinase inhibitor that blocks multiple pathways involved in cancer development.
